Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. scores highest on Torque (61) and lowest on Earnings (29). Its PosiPenta is 44.03 out of 100, around the middle of similar companies.
On the Penta Grid this week, Artiva Biotherapeutics, Inc. is Grid #406 of 837 in the Healthcare sector in United States, and Grid #2,504 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. | 44.03 | 41 | 29 | 45 | 61 | 44 |
| Surrozen, Inc. | 50.18 | 0 | 38 | 66 | 92 | 55 |
| Sanara MedTech Inc. | 55.94 | 1 | 87 | 94 | 39 | 59 |
| Arcturus Therapeutics Holdings Inc. | 37.40 | 31 | 20 | 47 | 49 | 40 |
| Benitec Biopharma Inc. | 42.20 | 32 | 25 | 28 | 69 | 56 |
| Turn Therapeutics Inc. | 39.98 | 0 | 61 | 71 | 4 | 64 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.81 |
| P/B ratio | 0.82 |
EEarnings
| Trailing EPS | ₹-305.93 |
| Forward EPS | ₹-247.02 |
NNitro
| Price | 554.08 |
| 52-week high | 1376.21 |
| 52-week low | 280.36 |
| Fall from 52-week high | 59.7% |
TTorque
| Return on equity (ROE) | -36.58% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | 2.41 |
| Market cap | ₹2,708 Cr |
| Insider holding | 15.10% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Artiva Biotherapeutics, Inc.'s PosiPenta score?
Artiva Biotherapeutics, Inc.'s PosiPenta is 44.03 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Artiva Biotherapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Artiva Biotherapeutics, Inc. is Grid #406 of 837 in the Healthcare sector in United States, and Grid #2,504 of 4,000 in United States.
Which PosiPenta pillar is strongest for Artiva Biotherapeutics, Inc.?
Torque (durability), with a score of 61 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Artiva Biotherapeutics, Inc.?
Earnings (growth), with a score of 29 out of 100: weaker than most similar companies.
Has Artiva Biotherapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.06 points, from 40.97 to 44.03.
PositoAI is for research and education only and is not investment advice.